Patents Examined by Ann Bucci
  • Patent number: 4567269
    Abstract: 5-isothiocyanato-2-methylquinolines, N-(2,2-dialkoxyethyl)-N'-(2-methylquinolin-5-yl)thioureas, 5-(2-mercaptoimidazol-1-yl)-2-methylquinolines, 5-(imidazol-1-yl)-2-methylquinolines, 5-(imidazol-1-yl)-1,2,3,4-tetrahydro-2-methylquinolines and dialkoxy 2-[N-(5-(imidazol-1-yl)-1,2,3,4-tetrahydro-2-methylquinolinyl)]methylenema lonates are described as intermediates for antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2- carboxylic acids.
    Type: Grant
    Filed: June 25, 1984
    Date of Patent: January 28, 1986
    Assignee: Riker Laboratories, Inc.
    Inventor: John F. Gerster
  • Patent number: 4560689
    Abstract: Disclosed are heterocyclic-fused pyrazolo[3,4-d]pyridin-3-ones useful as benzodiazepine receptor modulators.
    Type: Grant
    Filed: August 6, 1984
    Date of Patent: December 24, 1985
    Assignee: Ciba-Geigy Corporation
    Inventor: Naokata Yokoyama
  • Patent number: 4556667
    Abstract: Novel [2-[(aminopyridinyl)amino]phenyl]arylmethanones and their thioxomethyl, ketal or thioketal analogs of the formula: ##STR1## wherein; R is selected from the group consisting of hydrogen, loweralkyl, --alk.sup.1 --halo, --alk.sup.1 --NR.sup.1 --NR.sup.1 R.sup.2 or --alk.sup.1 --N.dbd.CH--OC.sub.2 H.sub.5 ;R.sup.1 and R.sup.2 are selected from the group consisting of hydrogen, loweralkyl, --C(O)O-loweralkyl or R.sup.1 and R.sup.2 taken together with the adjacent nitrogen atom may form a heterocyclic residue selected from the group consisting of 1-piperidinyl, 1-phthalimido, 1-pyrrolidinyl, 4-morpholinyl, 1-piperazinyl and 4-substituted-1-piperazinyl;B is selected from carbonyl, thioxomethyl, ketal or thioketal;Ar is selected from the group consisting of 2, 3 and 4-pyridinyl, 2 or 3-thienyl, phenyl or phenyl substituted by 1 to 3 radicals selected from halo, loweralkyl, loweralkoxy, trifluoromethyl or nitro and may be the same of different;alk.sup.
    Type: Grant
    Filed: December 9, 1983
    Date of Patent: December 3, 1985
    Assignee: A. H. Robins Company, Incorporated
    Inventor: Chandler R. Taylor, Jr.
  • Patent number: 4555515
    Abstract: Compounds having the formula ##STR1## in which R.sub.1 is hydrogen or C.sub.1 -C.sub.4 alkyl and R.sub.2 and R.sub.3 are C.sub.1 -C.sub.4 alkyl are insect repellents.
    Type: Grant
    Filed: February 25, 1985
    Date of Patent: November 26, 1985
    Assignee: Stauffer Chemical Co.
    Inventor: Rayman Y. Wong
  • Patent number: 4555511
    Abstract: Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, alkyl of 1 to 6 carbon atoms or phenyl (alkyl of 1 to 6 carbon atoms);R.sub.2 is hydrogen, alkyl of 1 to 4 carbon atoms or phenyl (alkyl of 1 to 6 carbon atoms);R.sub.3 is hydrogen or alkyl of 1 to 6 carbon atoms; and their use as antihypertensives.
    Type: Grant
    Filed: January 19, 1984
    Date of Patent: November 26, 1985
    Assignee: Boehringer Ingelheim KG
    Inventors: Gerd Schnorrenberg, Otto Roos, Walter Losel, Ingrid Wiedemann, Wolfram Gaida, Wolfgang Hoefke
  • Patent number: 4555514
    Abstract: The present invention relates to new compounds of the general formula: ##STR1## in which X represents oxygen or sulphur and R represents a linear or branched alkyl group with 1 to 7 carbon atoms,and pharmaceutically acceptable acid addition salts thereof, having valuable cardiovascular properties.
    Type: Grant
    Filed: January 9, 1985
    Date of Patent: November 26, 1985
    Assignee: Riom Laboratoires C.E.R.M. "RL-CERM" S.A.
    Inventors: Michel Combourieu, Jacques A. L. Simond, Andre J. Monteil
  • Patent number: 4548941
    Abstract: There are disclosed novel substituted and bridged pyridines which are useful as calcium channel blockers.
    Type: Grant
    Filed: July 30, 1984
    Date of Patent: October 22, 1985
    Assignee: Merck & Co., Inc.
    Inventors: Wasyl Halczenko, George D. Hartman
  • Patent number: 4547513
    Abstract: This invention relates to novel benzothiazoline derivatives of the formula [I] and salts thereof, ##STR1## wherein R.sup.1 is formyl or lower alkanoyl;R.sup.2 is hydrogen, lower alkyl, lower alkoxy or nitro;R.sup.3 is hydrogen, lower alkyl, lower alkoxy or halogen;A is lower alkylene;B is --CO--(CH.sub.2).sub.m -- or --CH(OH)--;m is 0 or 1; andwhen m is 0, R.sup.3 is not hydrogen.The compounds of this invention are useful for treatment of cardiovascular diseases.
    Type: Grant
    Filed: December 7, 1984
    Date of Patent: October 15, 1985
    Assignee: Santen Pharmaceutical Co., Ltd.
    Inventors: Jun-ichi Iwao, Tadashi Iso, Masayuki Oya
  • Patent number: 4544745
    Abstract: Cis-4a-aryl, 1, 2, 3, 4, 4A, 9B-hexahydro-benzofuro-[3,2-C]- pyridines, useful as analgesic and anticonvulsant agents are described.
    Type: Grant
    Filed: December 21, 1984
    Date of Patent: October 1, 1985
    Assignee: Hoechst-Roussel Pharmaceuticals Inc.
    Inventor: Solomon S. Klioze
  • Patent number: 4542138
    Abstract: 6H-3,11b-Dihydrocarbalkoxy-5,7-dioxobenzo[6,7]cyclohepta[1,2-c]pyridine compounds represented by the formula: ##STR1## wherein G is lower alkyl or halogen; R is lower alkyl, R' is hydrogen, lower alkyl, and n is from 0 to 2 and a process for their preparation are disclosed. The compounds have the property of inhibiting calcium induced contraction of the smooth muscle.
    Type: Grant
    Filed: May 8, 1984
    Date of Patent: September 17, 1985
    Assignee: Merck & Co., Inc.
    Inventor: Steven D. Young
  • Patent number: 4537964
    Abstract: Trans-(.+-.)-1-permissibly-substituted-2,6-dioxodecahydroquinoline or enantiomers thereof, intermediates for preparing tautomeric trans-(.+-.)-5-permissibly substituted octahydro-1H(and 2H)pyrazolo[3,4-g]quinolines, 4aR,8aR or 4aS,8aS enantiomers thereof, for preparing trans-(.+-.)-5-permissibly substituted-octahydropyrazolo (or oxazolo)[4,5-g]quinoline, 4aR,8aR or 4aS,8aS enantiomers thereof or for preparing trans-(.+-.)-6-permissibly-substituted octahydropyrimido[4,5-g]quinolines, a 5aR,9aR or 5aS,9aS enantiomer thereof said racemic intermediates being comprised of stereoisomers of the following formulas ##STR1## wherein R is H, alkyl or C.sub.1-3 straight-chain alkyl.
    Type: Grant
    Filed: August 3, 1984
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventor: John M. Schaus
  • Patent number: 4537620
    Abstract: Substituted aryloxyphenoxy acylisothioureas useful as herbicides having the formula ##STR1## wherein R is CF.sub.3 or halogen; X is hydrogen or halogen; A is CH or nitrogen; R.sub.1 is hydrogen, lower alkyl, alkenyl, alkynyl, phenyl, cyanoalkyl, alkoxyalkyl, or alkoxycarbonylalkyl; R.sub.2 is hydrogen, lower alkyl, phenyl, or substituted phenyl; and R.sub.3 is acyl or halogen substituted acyl selected from the group consisting of propionyl, dichloro bromoacetyl, propionaminocarbonyl and phenylaminocarbonyl.
    Type: Grant
    Filed: July 2, 1984
    Date of Patent: August 27, 1985
    Assignee: Stauffer Chemical Company
    Inventor: Ferenc M. Pallos
  • Patent number: 4537965
    Abstract: 4aR,8aR-5-permissibly substituted-6-oxo-octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines. The compounds are useful as intermediates in preparing dopamine D-2 agonists.
    Type: Grant
    Filed: August 3, 1984
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventor: Nancy G. Gallick-Whitaker
  • Patent number: 4537893
    Abstract: Trans-(.+-.) 2 and/or 5-permissibly substituted octahydrothiazolo[4,5-g]quinolines and acid addition or quaternary salts thereof and, individual enantiomers thereof, useful as dopamine agonists.
    Type: Grant
    Filed: April 27, 1984
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventors: Robert D. Titus, Edmund C. Kornfeld
  • Patent number: 4530929
    Abstract: A class of novel fused-ring, benzotricyclic, nitrogen-containing diones useful as agents in reversing electroconvulsive shock-induced amnesia. A method of preparing the compounds, pharmaceutical compositions including the compounds, and a method of reversing electroconvulsive shock-induced amnesia are disclosed.
    Type: Grant
    Filed: February 2, 1984
    Date of Patent: July 23, 1985
    Assignee: Warner-Lambert Company
    Inventors: Donald E. Butler, Michael R. Pavia, Fred M. Hershenson
  • Patent number: 4526967
    Abstract: The invention concerns benzoquinolizines of general formula ##STR1## and their pharmaceutically acceptable acid addition salts. In formula (I), R represents hydrogen or lower alkyl, R.sup.1 and R.sup.2 which may be the same or different each represent hydrogen, lower alkyl, lower alkoxy or halogen, R.sup.3 and R.sup.4 which may be the same or different each represents lower alkyl, halo(lower)alkyl or aryl and A represents a lower alkylene group having 1 to 3 carbon atoms in the chain between the two N atoms. The compounds possess .alpha..sub.2 -adrenoceptor antagonistic activity in warm blooded animals.
    Type: Grant
    Filed: March 19, 1984
    Date of Patent: July 2, 1985
    Assignee: John Wyeth & Brother Limited
    Inventor: Terence J. Ward
  • Patent number: 4525584
    Abstract: 4aR,8aS,9R-5-C.sub.1-3 straight-chain alkyl (methyl, ethyl or n-propyl) or allyl-9-hydroxy-octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines useful as hypotensives.
    Type: Grant
    Filed: August 3, 1984
    Date of Patent: June 25, 1985
    Assignee: Eli Lilly and Company
    Inventor: Nancy G. Gallick-Whitaker